Sjoerd den Uil

Research output

Research output per year 2009 2016 2023

• 8 Article
• 3 Meeting Abstract
• 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2023

  Prognostic biomarkers for stage II and III colon cancer

  den Uil, S. H., 14 Dec 2023, 160 p.

  Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

  Open Access
• 2022

  High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence

  Nugteren, S., den Uil, S. H., Delis-van Diemen, P. M., Simons-Oosterhuis, Y., Lindenbergh-Kortleve, D. J., van Haaften, D. H., Stockmann, H. B. A. C., Sanders, J., Meijer, G. A., Fijneman, R. J. A. & Samsom, J. N., 1 Dec 2022, In: Scientific reports. 12, 1, 12174.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)
• 2021

  Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer

  den Uil, S. H., de Wit, M., Slebos, R. J. C., Delis-van Diemen, P. M., Sanders, J., Piersma, S. R., Pham, T. V., Coupé, V. M. H., Bril, H., Stockmann, H. B. A. C., Jimenez, C. R., Meijer, G. A. & Fijneman, R. J. A., Feb 2021, In: European Journal of Cancer. 144, p. 91-100 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  12 Citations (Scopus)
• 2019

  Prognostic value of microvessel density in stage II and III colon cancer patients: A retrospective cohort study

  den Uil, S. H., van den Broek, E., Coupé, V. M. H., Vellinga, T. T., Delis-van Diemen, P. M., Bril, H., Belt, E. J. T., Kranenburg, O., Stockmann, H. B. A. C., Belien, J. A. M., Meijer, G. A. & Fijneman, R. J. A., 16 Aug 2019, In: BMC gastroenterology. 19, 1, 146.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  13 Citations (Scopus)
• 2018

  MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer

  van den Broek, E., den Uil, S. H., Coupé, V. M. H., Delis-van Diemen, P. M., Bolijn, A. S., Bril, H., Stockmann, H. B. A. C., van Grieken, N. C. T., Meijer, G. A. & Fijneman, R. J. A., 2018, In: Oncotarget. 9, 50, p. 29445-29452

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  9 Citations (Scopus)
• 2016

  Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion

  Vellinga, T. T., den Uil, S., Rinkes, I. H. B., Marvin, D., Ponsioen, B., Alvarez-Varela, A., Fatrai, S., Scheele, C., Zwijnenburg, D. A., Snippert, H., Vermeulen, L., Medema, J. P., Stockmann, H. B., Koster, J., Fijneman, R. J. A., de Rooij, J. & Kranenburg, O., 2016, In: Oncogene. 35, 40, p. 5263-5271 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  84 Citations (Scopus)

• Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients

  van den Broek, E., Krijgsman, O., Sie, D., Tijssen, M., Mongera, S., van de Wiel, M. A., Belt, E. J. T., den Uil, S. H., Bril, H., Stockmann, H. B. A. C., Ylstra, B., Carvalho, B., Meijer, G. A. & Fijneman, R. J. A., 8 Nov 2016, In: Oncotarget. 7, 45, p. 73876-73887

  Research output: Contribution to journal › Article › Academic › peer-review
  9 Citations (Scopus)

• KCNQ1 expression is a strong prognostic biomarker for disease recurrence in stage II and III colon cancer

  den Uil, S. H., Coupe, V. M. H., Linnekamp, J. F., van den Broek, E., Goos, J. A. C. M., Delis-van Diemen, P. M., Belt, E. J. T., van Grieken, N. C. T., Scott, P. M., Vermeulen, L., Medema, J. P., Bril, H., Stockmann, H. B. A. C., Cormier, R. T., Meijer, G. A. & Fijneman, R. J., Jul 2016, In: Cancer research. 76

  Research output: Contribution to journal › Meeting Abstract › Academic

• Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence

  den Uil, S. H., Coupé, V. M. H., Linnekamp, J. F., van den Broek, E., Goos, J. A. C. M., Delis-van Diemen, P. M., Belt, E. J. T., van Grieken, N. C. T., Scott, P. M., Vermeulen, L., Medema, J. P., Bril, H., Stockmann, H. B. A. C., Cormier, R. T., Meijer, G. A. & Fijneman, R. J. A., 6 Dec 2016, In: British journal of cancer. 115, 12, p. 1565-1574 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  30 Citations (Scopus)
• 2015

  MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients

  Lenos, K., Goos, J. A. C. M., Vuist, I. M., den Uil, S. H., Delis-van Diemen, P. M., Belt, E. J. T., Stockmann, H. B. A. C., Bril, H., de Wit, M., Carvalho, B., Giblett, S., Pritchard, C. A., Meijer, G. A., van Kooyk, Y., Fijneman, R. J. A. & van Vliet, S. J., 2015, In: Oncotarget. 6, 28, p. 26278-26290

  Research output: Contribution to journal › Article › Academic › peer-review
  35 Citations (Scopus)
• 2010

  A 'SMART' way to learn how to determine a therapeutic goal

  Tichelaar, J., den Uil, S. H., Swagerman, W. J. C., van Unen, R. J., Schneider, A. J., Pans, S. J. A., Richir, M. C. & de Vries, T. P. G., 2010, In: British journal of clinical pharmacology. 69, 6, p. 713-714

  Research output: Contribution to journal › Meeting Abstract › Other research output
• 2009

  A 'Smart' Way to Learn How to Determine A Therapeutic Goal

  Tichelaar, J., den Uil, S. H., Swagerman, W. J. C., van Unen, R. J., Schneider, A. J., Pans, S. J. A., Richir, M. C. & de Vries, T. P. G. M., 2009, In: Basic and Clinical Pharmacology and Toxicology. 105¬, p. 42-42

  Research output: Contribution to journal › Meeting Abstract › Other research output